Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma 59Lymphoma, Follicular 53Lymphoma, Large B-Cell, Diffuse 51Lymphoma, B-Cell 50Leukemia, Lymphocytic, Chronic, B-Cell 34Lymphoma, Non-Hodgkin 33Recurrence 27Leukemia 22Lymphoma, Mantle-Cell 20Burkitt Lymphoma 18Lymphoma, T-Cell, Peripheral 17Leukemia, Myeloid, Acute 15Hodgkin Disease 15Waldenstrom Macroglobulinemia 14Hematologic Neoplasms 14Lymphoma, B-Cell, Marginal Zone 13Multiple Myeloma 12Lymphoma, T-Cell, Cutaneous 12Lymphoma, Extranodal NK-T-Cell 12Neoplasms 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, B-Cell 8Motor Activity 7Myelodysplastic Syndromes 6Mycosis Fungoides 6Sezary Syndrome 5Neoplasm, Residual 5Pain 4Neoplasms, Plasma Cell 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Developmental Disabilities × Lymphoid × Clear all
NCT07092852 2025-07-30

PGx Medication Safety Reviews of Persons With IDD

GalenusRx, Inc.

Not yet recruiting
700 enrolled
Lymphoid

Developmental Disabilities, Lymphoma, Follicular, Intellectual Disability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡